Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn’s Disease Patients Treated with High-Dose Vitamin D Alone or Combined with Infliximab

Lignende værker

• Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn’s Disease during One-Year Follow-Up
  af: Bendix, Mia, et al.
  Udgivet: (2021)
• Vitamin D increases programmed death receptor-1 expression in Crohn’s disease
  af: Bendix, Mia, et al.
  Udgivet: (2017)
• Effects of Anti-TNFα Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn's Disease
  af: Dige, Anders, et al.
  Udgivet: (2018)
• Infliximab Induces Clonal Expansion of γδ-T Cells in Crohn's Disease: A Predictor of Lymphoma Risk?
  af: Kelsen, Jens, et al.
  Udgivet: (2011)
• Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease
  af: Bendix, M, et al.
  Udgivet: (2015)